• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肝衰竭与慢加急性肝衰竭:中国北京临床结局的比较分析

Acute versus acute-on-chronic liver failure: comparative analysis of clinical outcomes in Beijing, China.

作者信息

Guo Hebing, Yin Ningning, Liu Jingyuan, Li Ang

机构信息

Department of Critical Care Medicine, Beijing Ditan Hospital, Capital Medical University, Chaoyang District, Beijing, 100015, China.

出版信息

BMC Gastroenterol. 2025 Sep 3;25(1):637. doi: 10.1186/s12876-025-04234-x.

DOI:10.1186/s12876-025-04234-x
PMID:40898073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12406371/
Abstract

BACKGROUND

Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) pose significant threats to patient outcomes, frequently resulting in multiple organ dysfunction syndrome (MODS) and elevated mortality rates. This study investigates MODS outcomes among ALF and ACLF patients in China, identifying key factors that influence mortality and prognosis.

METHODS

A retrospective cohort analysis was conducted at a specialized tertiary hospital in Beijing, covering the period from June 2009 to May 2022, which included 585 patients:195 with ALF and 390 with ACLF.

RESULTS

Among these, 61% of ALF patients and 45.1% of ACLF patients developed MODS. ALF patients exhibited a higher incidence of organ failures and significantly higher median admission critical illness scores. Multivariate logistic regression analysis identified age, number of organ failures, and platelet count as independent predictors of 90-day mortality. Kaplan-Meier survival hazards analysis revealed significantly higher 90-day cumulative mortality rates for ALF patients compared to ACLF patients (33.8% vs. 25.9%, p = 0.009).

CONCLUSION

Approximately 50% of liver failure patients progress to MODS, with ALF patients demonstrating a higher incidence of MODS and poorer 90-day prognoses.

摘要

背景

急性肝衰竭(ALF)和慢加急性肝衰竭(ACLF)对患者预后构成重大威胁,常导致多器官功能障碍综合征(MODS)并使死亡率升高。本研究调查了中国ALF和ACLF患者的MODS转归情况,确定了影响死亡率和预后的关键因素。

方法

在北京一家三级专科医院进行了一项回顾性队列分析,涵盖2009年6月至2022年5月期间的585例患者:195例ALF患者和390例ACLF患者。

结果

其中,61%的ALF患者和45.1%的ACLF患者发生了MODS。ALF患者的器官衰竭发生率更高,入院时的中位危重病评分显著更高。多因素逻辑回归分析确定年龄、器官衰竭数量和血小板计数为90天死亡率的独立预测因素。Kaplan-Meier生存风险分析显示,ALF患者的90天累积死亡率显著高于ACLF患者(33.8%对25.9%,p = 0.009)。

结论

约50%的肝衰竭患者进展为MODS,ALF患者的MODS发生率更高,90天预后更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/0f556800a574/12876_2025_4234_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/e63357c3e603/12876_2025_4234_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/5775cea7ce83/12876_2025_4234_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/0f556800a574/12876_2025_4234_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/e63357c3e603/12876_2025_4234_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/5775cea7ce83/12876_2025_4234_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/12406371/0f556800a574/12876_2025_4234_Fig3_HTML.jpg

相似文献

1
Acute versus acute-on-chronic liver failure: comparative analysis of clinical outcomes in Beijing, China.急性肝衰竭与慢加急性肝衰竭:中国北京临床结局的比较分析
BMC Gastroenterol. 2025 Sep 3;25(1):637. doi: 10.1186/s12876-025-04234-x.
2
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF).采用Cytosorb和持续静脉-静脉血液透析滤过的人工肝支持与用于高胆红素血症和慢加急性肝衰竭(ACLF)重症患者的高级器官支持(ADVOS)的对比研究
BMC Nephrol. 2025 Aug 4;26(1):432. doi: 10.1186/s12882-025-04342-6.
3
Dynamic nomogram predicts sepsis risk in patients with acute liver failure: Analysis of intensive care database with external validation.动态列线图预测急性肝衰竭患者的脓毒症风险:重症监护数据库分析及外部验证
World J Gastroenterol. 2025 Aug 21;31(31):105229. doi: 10.3748/wjg.v31.i31.105229.
4
[Predictive value of liver-to-spleen volume ratio for short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure].[乙肝病毒相关慢加急性肝衰竭患者肝脾体积比对于短期预后的预测价值]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1989-1996. doi: 10.3760/cma.j.cn112137-20250222-00424.
5
Impact of artificial liver plasma perfusion combined with plasma exchange therapy on clinical efficacy and short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure with or without HIV infection.人工肝血浆灌注联合血浆置换疗法对合并或未合并HIV感染的乙型肝炎病毒相关慢加急性肝衰竭临床疗效及短期预后的影响
BMC Infect Dis. 2025 Aug 30;25(1):1081. doi: 10.1186/s12879-025-11496-z.
6
Lipid metabolism disturbance and immune dysfunction in HBV-related acute-on-chronic liver failure: a retrospective cohort study.乙型肝炎病毒相关慢加急性肝衰竭中脂质代谢紊乱与免疫功能障碍:一项回顾性队列研究
BMC Gastroenterol. 2025 Jul 1;25(1):444. doi: 10.1186/s12876-025-04004-9.
7
Persistent Lymphopenia as a Poor Prognostic Factor in Patients With Multiple Organ Dysfunction Syndrome in the Renal Intensive Care Unit: A Retrospective Single-Center Study.持续性淋巴细胞减少作为肾内科重症监护病房多器官功能障碍综合征患者的不良预后因素:一项回顾性单中心研究
Immun Inflamm Dis. 2025 Feb;13(2):e70152. doi: 10.1002/iid3.70152.
8
Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosis.鉴定和验证RIPK3作为预测急性失代偿期肝硬化患者预后的新型生物标志物。
J Hepatol. 2025 Aug 12. doi: 10.1016/j.jhep.2025.07.034.
9
Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study.一种预测慢性乙型肝炎急性肝衰竭移植后1年死亡率的新型预后模型的开发与验证:一项全国性、多中心队列研究。
EClinicalMedicine. 2025 Jul 17;86:103365. doi: 10.1016/j.eclinm.2025.103365. eCollection 2025 Aug.
10
Association between early antibiotic treatment after admission and mortality of acute-on-chronic liver failure patients with bacterial infection: A multicenter retrospective study.入院后早期抗生素治疗与慢性肝衰竭急性发作合并细菌感染患者死亡率之间的关联:一项多中心回顾性研究。
Virulence. 2025 Dec;16(1):2509757. doi: 10.1080/21505594.2025.2509757. Epub 2025 May 29.

本文引用的文献

1
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns.急慢性肝衰竭的重症监护管理:确定因素和未知因素。
Semin Liver Dis. 2023 May;43(2):206-217. doi: 10.1055/s-0043-1769907. Epub 2023 Jun 27.
2
Management of the acute on chronic liver failure in the intensive care unit.重症监护病房中慢性肝功能衰竭急性发作的管理。
Liver Int. 2025 Mar;45(3):e15659. doi: 10.1111/liv.15659. Epub 2023 Jun 27.
3
Organ dysfunction and failure in liver disease.肝脏疾病中的器官功能障碍与衰竭
Liver Int. 2025 Mar;45(3):e15622. doi: 10.1111/liv.15622. Epub 2023 May 24.
4
Bacterial and fungal infections: a frequent and deadly complication among critically ill acute liver failure patients.细菌和真菌感染:重症急性肝衰竭患者中常见且致命的并发症。
Infect Dis (Lond). 2023 Jul;55(7):480-489. doi: 10.1080/23744235.2023.2213326. Epub 2023 May 21.
5
Epidemiology, characteristics, and outcomes of patients with acute-on-chronic liver failure in Australia.澳大利亚慢加急性肝衰竭患者的流行病学、特征和结局。
J Gastroenterol Hepatol. 2023 Aug;38(8):1325-1332. doi: 10.1111/jgh.16197. Epub 2023 Apr 25.
6
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations.成人 ICU 急性和慢加急性肝衰竭管理指南:神经病学、移植围手术期医学、传染病学和胃肠病学的考虑。
Crit Care Med. 2023 May 1;51(5):657-676. doi: 10.1097/CCM.0000000000005824. Epub 2023 Apr 13.
7
Electrolyte Imbalance and Neurologic Injury.电解质失衡与神经损伤。
CNS Neurol Disord Drug Targets. 2024;23(7):841-851. doi: 10.2174/1871527322666230215144649.
8
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure.肺部损伤独立决定了急性慢性肝衰竭重症患者的死亡率。
Liver Int. 2023 Jan;43(1):180-193. doi: 10.1111/liv.15343. Epub 2022 Aug 25.
9
Intensive care management of acute-on-chronic liver failure.慢性肝衰竭急性发作的重症监护管理。
J Hepatol. 2021 Jul;75 Suppl 1:S163-S177. doi: 10.1016/j.jhep.2020.10.024.
10
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge.肝硬化患者细菌和真菌感染的管理:多重耐药菌的挑战。
J Hepatol. 2021 Jul;75 Suppl 1:S101-S117. doi: 10.1016/j.jhep.2020.11.010.